Exscientia PLC

World Rank (Jan-05-2024)

10,187

Market Cap (Jan-05-2024)

0.745 Billion USD

World Rank (Jul-30-2023)

8,949

Market Cap (Jul-30-2023)

0.956 Billion USD

World Rank (Jan-07-2022)

5,579

Market Cap (Jan-07-2022)

2.415 Billion USD

Headquarters Country

UK

Nasdaq / NYSE Code

EXAI

World Region

World Subregion

Business Sector

Company Website

Company Profile

Exscientia plc is a biotechnology company with automate drug design and are the first to have an AI Designed molecule enter clinical trials. The company annual revenue is 9.6 million GBP and total assets are 77.7 million GBP as on 2020. The headquarters is in UK.

Founded Year

2012

IPO Year

2021

Stock Exchange

Nasdaq

Nasdaq Sector

Health Care

Nasdaq Industry

Biotechnology: Biological Products (No Diagnostic Substances)